Published online 30 May 2006 doi:10.1084/jem.20060657
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 6, 1533-1541
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge
Joseph J. Mattapallil1,
Daniel C. Douek1,
Alicia Buckler-White2,
David Montefiori3,
Norman L. Letvin4,
Gary J. Nabel1, and
Mario Roederer1
1 Vaccine Research Center and 2 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
3 Duke University Medical Center, Durham, NC 27710
4 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
CORRESPONDENCE M. Roederer: roederer{at}nih.gov
Acute simian immunodeficiency virus (SIV)/human immunodeficiency virus infection is accompanied by a massive destruction of CD4 memory T cells across all the tissue compartments. These early events set the course toward disease progression and immunodeficiency. Here, we demonstrate that prior vaccination reduces this destruction during acute SIV Mac251 infection, leading to better survival and long-term outcome. Systemic vaccination with a DNA-prime recombinant adenovirus boost regimen preserved memory CD4 T cells throughout the body. The vaccine regimen induced broad CD4 and CD8 T cell responses in all tissues examined and, importantly, induced antibodies that neutralized the primary isolate of SIV used for challenge. Finally, we demonstrate that the extent of preservation of the CD4 memory compartment during the acute phase provides a strong predictor for subsequent progression to death. Our data provide a mechanism to explain clinical observations that acute-phase viral loads predict long-term disease progression and underscore the need for interventions that protect against early destruction of CD4 memory T cells during acute infection.
Abbreviations used: qPCR, quantitative PCR; rAd, recombinant adenovirus; SIV, simian immunodeficiency virus; TCLA, T cell lineadapted; VL, viral load.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Vaccari, M., Mattapallil, J., Song, K., Tsai, W.-P., Hryniewicz, A., Venzon, D., Zanetti, M., Reimann, K. A., Roederer, M., Franchini, G.
(2008). Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency. J. Virol.
82: 9629-9638
[Abstract]
[Full Text]
-
Kaufman, D. R., Liu, J., Carville, A., Mansfield, K. G., Havenga, M. J. E., Goudsmit, J., Barouch, D. H.
(2008). Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination. J. Immunol.
181: 4188-4198
[Abstract]
[Full Text]
-
Chege, G. K., Shephard, E. G., Meyers, A., van Harmelen, J., Williamson, C., Lynch, A., Gray, C. M., Rybicki, E. P., Williamson, A.-L.
(2008). HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine. J. Gen. Virol.
89: 2214-2227
[Abstract]
[Full Text]
-
Fauci, A. S., Johnston, M. I., Dieffenbach, C. W., Burton, D. R., Hammer, S. M., Hoxie, J. A., Martin, M., Overbaugh, J., Watkins, D. I., Mahmoud, A., Greene, W. C.
(2008). HIV Vaccine Research: The Way Forward. Science
321: 530-532
[Abstract]
[Full Text]
-
Kitabwalla, M., Ansari, A. A., Villinger, F., Akeefe, H., Conner, A. P., Mayne, A. E., Hildreth, J. E. K.
(2008). Delipidated Retroviruses as Potential Autologous Therapeutic Vaccines--A Pilot Experiment. Exp. Biol. Med.
233: 732-740
[Abstract]
[Full Text]
-
Liu, J., Ewald, B. A., Lynch, D. M., Denholtz, M., Abbink, P., Lemckert, A. A. C., Carville, A., Mansfield, K. G., Havenga, M. J., Goudsmit, J., Barouch, D. H.
(2008). Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys. J. Virol.
82: 4844-4852
[Abstract]
[Full Text]
-
Calarota, S. A., Foli, A., Maserati, R., Baldanti, F., Paolucci, S., Young, M. A., Tsoukas, C. M., Lisziewicz, J., Lori, F.
(2008). HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals. J. Immunol.
180: 5907-5915
[Abstract]
[Full Text]
-
Verhoeven, D., Sankaran, S., Silvey, M., Dandekar, S.
(2008). Antiviral Therapy during Primary Simian Immunodeficiency Virus Infection Fails To Prevent Acute Loss of CD4+ T Cells in Gut Mucosa but Enhances Their Rapid Restoration through Central Memory T Cells. J. Virol.
82: 4016-4027
[Abstract]
[Full Text]
-
Schoenly, K. A., Weiner, D. B.
(2008). Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform "Spotty Business". J. Virol.
82: 3166-3180
[Full Text]
-
Sahaf, B., Atkuri, K., Heydari, K., Malipatlolla, M., Rappaport, J., Regulier, E., Herzenberg, L. A., Herzenberg, L. A.
(2008). Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc. Natl. Acad. Sci. USA
105: 5111-5116
[Abstract]
[Full Text]
-
Giraldo-Vela, J. P., Rudersdorf, R., Chung, C., Qi, Y., Wallace, L. T., Bimber, B., Borchardt, G. J., Fisk, D. L., Glidden, C. E., Loffredo, J. T., Piaskowski, S. M., Furlott, J. R., Morales-Martinez, J. P., Wilson, N. A., Rehrauer, W. M., Lifson, J. D., Carrington, M., Watkins, D. I.
(2008). The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers. J. Virol.
82: 859-870
[Abstract]
[Full Text]
-
Duvall, M. G., Lore, K., Blaak, H., Ambrozak, D. A., Adams, W. C., Santos, K., Geldmacher, C., Mascola, J. R., McMichael, A. J., Jaye, A., Whittle, H. C., Rowland-Jones, S. L., Koup, R. A.
(2007). Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection. J. Virol.
81: 13486-13498
[Abstract]
[Full Text]
-
Tsukamoto, T., Yuasa, M., Yamamoto, H., Kawada, M., Takeda, A., Igarashi, H., Matano, T.
(2007). Induction of CD8+ Cells Able To Suppress CCR5-Tropic Simian Immunodeficiency Virus SIVmac239 Replication by Controlled Infection of CXCR4-Tropic Simian-Human Immunodeficiency Virus in Vaccinated Rhesus Macaques. J. Virol.
81: 11640-11649
[Abstract]
[Full Text]
-
Kwissa, M., Amara, R. R., Robinson, H. L., Moss, B., Alkan, S., Jabbar, A., Villinger, F., Pulendran, B.
(2007). Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J. Exp. Med.
204: 2733-2746
[Abstract]
[Full Text]
-
Rollman, E., Smith, M. Z., Brooks, A. G., Purcell, D. F. J., Zuber, B., Ramshaw, I. A., Kent, S. J.
(2007). Killing Kinetics of Simian Immunodeficiency Virus-Specific CD8+ T Cells: Implications for HIV Vaccine Strategies. J. Immunol.
179: 4571-4579
[Abstract]
[Full Text]
-
Wilson, D. P., Mattapallil, J. J., Lay, M. D. H., Zhang, L., Roederer, M., Davenport, M. P.
(2007). Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIVmac251 in the Gut. J. Virol.
81: 8025-8029
[Abstract]
[Full Text]
-
Petrovas, C., Price, D. A., Mattapallil, J., Ambrozak, D. R., Geldmacher, C., Cecchinato, V., Vaccari, M., Tryniszewska, E., Gostick, E., Roederer, M., Douek, D. C., Morgan, S. H., Davis, S. J., Franchini, G., Koup, R. A.
(2007). SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood
110: 928-936
[Abstract]
[Full Text]
-
Belyakov, I. M., Isakov, D., Zhu, Q., Dzutsev, A., Berzofsky, J. A.
(2007). A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T Cells. J. Immunol.
178: 7211-7221
[Abstract]
[Full Text]
-
Johnston, M. I., Fauci, A. S.
(2007). An HIV Vaccine -- Evolving Concepts. NEJM
356: 2073-2081
[Full Text]
-
Kawada, M., Tsukamoto, T., Yamamoto, H., Takeda, A., Igarashi, H., Watkins, D. I., Matano, T.
(2007). Long-Term Control of Simian Immunodeficiency Virus Replication with Central Memory CD4+ T-Cell Preservation after Nonsterile Protection by a Cytotoxic T-Lymphocyte-Based Vaccine. J. Virol.
81: 5202-5211
[Abstract]
[Full Text]
-
Loffredo, J. T., Burwitz, B. J., Rakasz, E. G., Spencer, S. P., Stephany, J. J., Giraldo Vela, J. P., Martin, S. R., Reed, J., Piaskowski, S. M., Furlott, J., Weisgrau, K. L., Rodrigues, D. S., Soma, T., Napoe, G., Friedrich, T. C., Wilson, N. A., Kallas, E. G., Watkins, D. I.
(2007). The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape. J. Virol.
81: 2624-2634
[Abstract]
[Full Text]
-
De Boer, R. J.
(2007). Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus. J. Virol.
81: 2838-2848
[Abstract]
[Full Text]
-
Yamamoto, H., Kawada, M., Tsukamoto, T., Takeda, A., Igarashi, H., Miyazawa, M., Naruse, T., Yasunami, M., Kimura, A., Matano, T.
(2007). Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. J. Gen. Virol.
88: 652-659
[Abstract]
[Full Text]